Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - TOTAL CURRENT LIABILITIES
Total Current Liabilities REGN - Regeneron Pharmaceuticals, Inc.
3.42 B
LAST VALUE
-0.40%
2 YEAR CAGR
20.42%
5 YEAR CAGR
29.29%
10 YEAR CAGR